SH1

N-[(2-PHENYLETHYL)SULFONYL]-D-SERYL-N-[(1S)-4-[(DIAMINOMETHYLENE)AMINO]-1-(HYDROXYMETHYL)BUTYL]-L-ALANINAMIDE

Created:	2004-06-15
Last modified:	2024-09-27

Find Related PDB Entry
1 entries where SH1 is covalently linked to polymer or other heterogen groups

Find related ligands:

Similar Ligands (Stereospecific) Similar Ligands (including Stereoisomers) Similar Ligands (Quick Screen) Similar Ligands (Substructure Stereospecific) Similar Ligands (Substructure including Stereoisomers)

Chemical Details
Formal Charge	0
Atom Count	67
Chiral Atom Count	3
Bond Count	67
Aromatic Bond Count	6

2D diagram of SH1

Toggle Hydrogen Toggle Labels

Chemical Component Summary
Name	N-[(2-PHENYLETHYL)SULFONYL]-D-SERYL-N-[(1S)-4-[(DIAMINOMETHYLENE)AMINO]-1-(HYDROXYMETHYL)BUTYL]-L-ALANINAMIDE
Systematic Name (OpenEye OEToolkits)	(2R)-N-[(2S)-1-[[(2S)-5-(diaminomethylideneamino)-1-hydroxy-pentan-2-yl]amino]-1-oxo-propan-2-yl]-3-hydroxy-2-(phenethylsulfonylamino)propanamide
Formula	C₂₀ H₃₄ N₆ O₆ S
Molecular Weight	486.586
Type	NON-POLYMER

Chemical Descriptors
Type	Program	Version	Descriptor
SMILES	ACDLabs	10.04	O=C(NC(CCC/N=C(\N)N)CO)C(NC(=O)C(NS(=O)(=O)CCc1ccccc1)CO)C
SMILES	CACTVS	3.341	C[CH](NC(=O)[CH](CO)N[S](=O)(=O)CCc1ccccc1)C(=O)N[CH](CO)CCCN=C(N)N
SMILES	OpenEye OEToolkits	1.5.0	CC(C(=O)NC(CCCN=C(N)N)CO)NC(=O)C(CO)NS(=O)(=O)CCc1ccccc1
Canonical SMILES	CACTVS	3.341	C[C@H](NC(=O)[C@@H](CO)N[S](=O)(=O)CCc1ccccc1)C(=O)N[C@H](CO)CCCN=C(N)N
Canonical SMILES	OpenEye OEToolkits	1.5.0	C[C@@H](C(=O)N[C@@H](CCCN=C(N)N)CO)NC(=O)[C@@H](CO)NS(=O)(=O)CCc1ccccc1
InChI	InChI	1.03	InChI=1S/C20H34N6O6S/c1-14(18(29)25-16(12-27)8-5-10-23-20(21)22)24-19(30)17(13-28)26-33(31,32)11-9-15-6-3-2-4-7-15/h2-4,6-7,14,16-17,26-28H,5,8-13H2,1H3,(H,24,30)(H,25,29)(H4,21,22,23)/t14-,16-,17+/m0/s1
InChIKey	InChI	1.03	RWZMJXITHWDHNE-BHYGNILZSA-N

Related Resource References

Resource Name	Reference
PubChem	49867649

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.